Inflectis Bioscience

France

 
Quantité totale PI 16
Rang # Quantité totale PI 94 003
Note d'activité PI 1,7/5.0    9
Rang # Activité PI 101 667
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

5 1
3 0
6 1
0
 
Dernier brevet 2024 - Benzylideneaminoguanidine deriva...
Premier brevet 2014 - Benzylideneguanidine derivatives...
Dernière marque 2013 - InFlectis BioScience
Première marque 2013 - InFlectis BioScience

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Novel combinations useful for the treatments of als. The present invention concerns the treatment...
Invention Benzylideneaminoguanidine derivatives as nr2b-selective nmda receptor antagonists and their thera...
2020 Invention Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies. T...
2019 Invention O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders assoc...
Invention Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding dise...
2016 Invention Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherape...
2015 Invention Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies. The pres...
Invention Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies. Th...
2013 P/S Pharmaceutical and veterinary products; sanitary products for medical purposes; dietetic food an...
P/S [ Prophylactic and therapeutic medicines for human and animal health to prevent or treat disorder...